Chimeric plasmids

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4663285
SERIAL NO

06558697

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A plasmid selected from (a) a plasmid conferring resistance to tetracyline (Tc.sup.r) and neomycin (Neo.sup.r) on a host, and being built up by the in vitro ligation of a Neo.sup.r non-chimeric plasmid and a Tc.sup.r non-chimeric plasmid, (b) a deletion, insertion or deletion/insertion derivative of a group (a) plasmid, or (c) a rearrangement derivative of a group (a) or group (b) plasmid are disclosed. The host may be a Bacillus, particularly Bacillus subtilis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PUBLIC HEALTH LABORATORY SERVICE BOARDLONDON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Atkinson, Anthony Salisbury, GB2 32 450
Bingham, Alistair H A Geneva, CH 1 1
Bruton, Christopher J Richmond, GB2 2 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation